search
Back to results

DIgital Online SuPport for COVID-19 StrEss (DISPOSE)

Primary Purpose

COVID-19, Psychosocial Stress, Mental Health

Status
Unknown status
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Guided online support program
WHO recommendations (waiting condition)
Sponsored by
Gunther Meinlschmidt
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for COVID-19 focused on measuring COVID-19, SARS-CoV-2, psychosocial stress, online support, guided, mental health, anxiety, depression, somatic symptom disorder

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesAccepts Healthy Volunteers

Inclusion criteria, general:

  • Sufficient German language skills to participate in the assessments.
  • Providing informed consent for participation.

Inclusion criteria for the arms "Online support program" and "Waiting condition...":

- Having signed up for the online support program provided by selfapy GmbH, Berlin, Germany (www.selfapy.de/corona) aiming at reducing burden in the context of the COVID-19 pandemic.

Inclusion criteria for the arm "No intervention...":

- Not having signed up for the online support program provided by selfapy GmbH, Berlin, Germany (www.selfapy.de/corona) aiming at reducing burden in the context of the COVID-19 pandemic.

Sites / Locations

  • Selfapy GmbHRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Experimental

Active Comparator

No Intervention

Arm Label

Online support program

Waiting period (WHO recommendation)

No intervention (natural course)

Arm Description

Guided online support program, consisting of modules (structured in chapters) aiming at reduce stress related to the COVID-19 pandemic.

Waiting period (2 weeks duration) during which subjects are provided with the WHO recommendations "Coping with stress during the 2019 nCoV outbreak". Following the 2 weeks waiting period, subjects are provided with the guided online support program outlined in the arm 'online support program'.

This non-randomised arm (recruited separately; anticipated sample size of 500 subjects, not counted in the overall anticipated sample size) consists of subjects not intending to participate in the Selfapy online support program. Assessment points in this arm are comparable to those in the arm "Online support program" (in the 'No intervention (natural course)' arm, T1 refers to time of study inclusion).

Outcomes

Primary Outcome Measures

Change in Short-Form-36 (SF-36) Health Survey - Mental Health Component Summary score
The SF-36 is a widely used patient-reported outcome assessment tool to measure health-related quality of life and has high acceptability. The SF-36 is a standardised questionnaire with good psychometric properties.

Secondary Outcome Measures

Short-Form-36 (SF-36) Health Survey - Mental Health Component Summary score
mental health related quality of life
Chronic stress items (9 items)
Assessing chronic stress (Petrowski et al., 2019)
Generalized Anxiety Disorder Scale (GAD-7)
Assessing anxiety symptoms (Löwe et al., 2008)
Patient Health Questionnaire (PHQ8)
Assessing depressive symptoms (Kroenke et al., 2001)
Somatic Symptom Disorder (SSD-12)
Assessing depressive symptoms (Toussaint et al., 2019)
Somatic Symptom Scale (SSS-8)
Assessing somatic symptoms (Gierk et al., 2015)
Allgemeine Selbstwirksamkeit Kurzskala (ASKU)
competence expectations to deal with difficulties and obstacles in daily life (Beierlein et al., 2014)
Screening Tool for Psychological Distress (STOP-D) - selected items
stress, anxiety, depression, social support - single item assessments to be applied repeatedly along the online support intervention (Young, Ignaszewski, Fofonoff, Kaan; 2007), including stress of children and anticipation

Full Information

First Posted
March 26, 2020
Last Updated
April 11, 2020
Sponsor
Gunther Meinlschmidt
Collaborators
Selfapy GmbH
search

1. Study Identification

Unique Protocol Identification Number
NCT04324190
Brief Title
DIgital Online SuPport for COVID-19 StrEss
Acronym
DISPOSE
Official Title
Online Support for Psychosocial Stress in the Context of the COVID-19 Pandemic
Study Type
Interventional

2. Study Status

Record Verification Date
April 2020
Overall Recruitment Status
Unknown status
Study Start Date
April 8, 2020 (Actual)
Primary Completion Date
June 2020 (Anticipated)
Study Completion Date
December 2021 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Gunther Meinlschmidt
Collaborators
Selfapy GmbH

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The COVID-19 pandemic leads to a greatly increased risk of substantial psychological stress worldwide. We intend to evaluate an online support program aiming at reducing stress in the context of the COVID-19 pandemic. The program consists of twelve modules that participants undergo, covering a broad range of topics related to stress in the context of the COVID-19 pandemic. It has been developed together with and is provided by Selfapy GmbH, Berlin. The aim of this randomised clinical trial with observational components is to estimate the effects of the intervention as a whole, as well as individual modules and selected chapters. Further, follow-up assessments as well as information on risks and the long-term course of COVID pandemic-related stress may help to elucidate COVID-19 pandemic stress across time and what we can do to prevent long-term negative consequences.
Detailed Description
The overall aim of this randomised trial with observational component is to estimate the effects of a guided digital online support program to increase mental health and reduce psychosocial stress in the context of the COVID-19 pandemic. More specifically, the main hypothesis is to estimate whether the improvement in mental health is stronger during the first two weeks of applying the online support program as compared to a two weeks waiting condition (with provision of WHO information on 'coping with stress during the 2019-nCoV' outbreak only). In addition to the randomised control group (second arm: waiting condition, followed by online support program), the study comprises as third arm a non-randomised comparator condition, consisting of subjects not intending to participate in the online support program. Furthermore, our aim is to estimate changes in the outcomes along taking part in the program. Additional research questions are: to compare the intervention effects across modules and chapters of the online support program, including between module comparison with an unspecific, control (comparator) module: "general information on the corona virus" and its unspecific chapters; to estimate the effects of selected modules on additional outcomes (e.g. physical activity, and schooling related factors); to describe the magnitude and course of psychosocial stress, mental health and related factors in the context of the COVID-19 pandemic; to estimate and predict which subjects profit most from specific parts of the program. Follow-up assessment shall include estimating whether the program prevents the development of detrimental mental health conditions, e.g. depression, anxiety, etc. In order to make first study results available as early as possible, we intend to conduct quick complete analyses (primary outcome and relevant parts of secondary/other outcomes): These analyses will be conducted with data including subjects from the first 4 weeks of recruitment, given that a sample size of at least 300 for the online support program arm and a sample size of at least 300 for the waiting condition is reached; or if not yet reached after 4 weeks of recruitment, as soon as a sample size of at least 300 for the online support program arm and a sample size of at least 300 for the waiting condition is reached. However, we intend to continue recruiting beyond this point in time and sample size (until the COVID-19 pandemic situation has come to an end, i.e., vaccination is broadly available), to allow further, also more detailed analyses at a later point in time, resulting in more precise estimates.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
COVID-19, Psychosocial Stress, Mental Health
Keywords
COVID-19, SARS-CoV-2, psychosocial stress, online support, guided, mental health, anxiety, depression, somatic symptom disorder

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Sequential Assignment
Model Description
Randomized controlled trial with a waiting comparator condition (provision of WHO recommendations, comparable to treatment as usual, TAU), consisting of a two weeks waiting period during which general WHO recommendations how to handle stress in the context of the COVID-19 pandemic will be provided. All subjects in the waiting condition will undergo the intervention following the waiting period. Main assessments will be conducted before the waiting period, before beginning of the intervention, two weeks after beginning of the intervention (+2 weeks), +4 weeks, +12 weeks, and follow ups at +6 months and +12 months.
Masking
Care Provider
Masking Description
Care providers (providing guidance) are not informed about wether participants have been assigned to the online support program condition or the comparator condition, consisting of a waiting period followed by the online support program.
Allocation
Randomized
Enrollment
600 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
Online support program
Arm Type
Experimental
Arm Description
Guided online support program, consisting of modules (structured in chapters) aiming at reduce stress related to the COVID-19 pandemic.
Arm Title
Waiting period (WHO recommendation)
Arm Type
Active Comparator
Arm Description
Waiting period (2 weeks duration) during which subjects are provided with the WHO recommendations "Coping with stress during the 2019 nCoV outbreak". Following the 2 weeks waiting period, subjects are provided with the guided online support program outlined in the arm 'online support program'.
Arm Title
No intervention (natural course)
Arm Type
No Intervention
Arm Description
This non-randomised arm (recruited separately; anticipated sample size of 500 subjects, not counted in the overall anticipated sample size) consists of subjects not intending to participate in the Selfapy online support program. Assessment points in this arm are comparable to those in the arm "Online support program" (in the 'No intervention (natural course)' arm, T1 refers to time of study inclusion).
Intervention Type
Behavioral
Intervention Name(s)
Guided online support program
Other Intervention Name(s)
online intervention, guided online support
Intervention Description
Guided online support program consisting of several modules; Module "General information ..." is an unspecific control module (providing general information on hygiene etc. with no expected effect on outcomes)
Intervention Type
Behavioral
Intervention Name(s)
WHO recommendations (waiting condition)
Intervention Description
During the waiting period, a german translation of the WHO recommendations "Coping with stress during the 2019-nCoV outbreak" is provided
Primary Outcome Measure Information:
Title
Change in Short-Form-36 (SF-36) Health Survey - Mental Health Component Summary score
Description
The SF-36 is a widely used patient-reported outcome assessment tool to measure health-related quality of life and has high acceptability. The SF-36 is a standardised questionnaire with good psychometric properties.
Time Frame
Change from T1 (baseline before online support - day 1) to T2 (T1 + 2 weeks) in arm 1, versus change from T0 (baseline before waiting) to T1 (baseline before online support) in arm 2
Secondary Outcome Measure Information:
Title
Short-Form-36 (SF-36) Health Survey - Mental Health Component Summary score
Description
mental health related quality of life
Time Frame
T2 (T1+2 weeks) (arm 2 only), T3 (T1+4 weeks), T4 (T1+12 weeks), follow ups: T1+ 6 months, T1+12 months
Title
Chronic stress items (9 items)
Description
Assessing chronic stress (Petrowski et al., 2019)
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T2 (T1+2 weeks), T3 (T1+4 weeks), T4 (T1+12 weeks), follow ups: T1+ 6 months, T1+12 months
Title
Generalized Anxiety Disorder Scale (GAD-7)
Description
Assessing anxiety symptoms (Löwe et al., 2008)
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T2 (T1+2 weeks), T3 (T1+4 weeks), T4 (T1+12 weeks), follow ups: T1+ 6 months, T1+12 months
Title
Patient Health Questionnaire (PHQ8)
Description
Assessing depressive symptoms (Kroenke et al., 2001)
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T2 (T1+2 weeks), T3 (T1+4 weeks), T4 (T1+12 weeks), follow ups: T1+ 6 months, T1+12 months
Title
Somatic Symptom Disorder (SSD-12)
Description
Assessing depressive symptoms (Toussaint et al., 2019)
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T2 (T1+2 weeks), T3 (T1+4 weeks), T4 (T1+12 weeks), follow ups: T1+ 6 months, T1+12 months
Title
Somatic Symptom Scale (SSS-8)
Description
Assessing somatic symptoms (Gierk et al., 2015)
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T2 (T1+2 weeks), T3 (T1+4 weeks), T4 (T1+12 weeks), follow ups: T1+ 6 months, T1+12 months
Title
Allgemeine Selbstwirksamkeit Kurzskala (ASKU)
Description
competence expectations to deal with difficulties and obstacles in daily life (Beierlein et al., 2014)
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T2 (T1+2 weeks), T3 (T1+4 weeks), T4 (T1+12 weeks), follow ups: T1+ 6 months, T1+12 months
Title
Screening Tool for Psychological Distress (STOP-D) - selected items
Description
stress, anxiety, depression, social support - single item assessments to be applied repeatedly along the online support intervention (Young, Ignaszewski, Fofonoff, Kaan; 2007), including stress of children and anticipation
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T1+2 weeks, T1+4 weeks, T1+12 weeks, follow ups: T1+ 6 months, T1+12 months; before & after each module of the online intervention
Other Pre-specified Outcome Measures:
Title
Physical activity
Description
Vigorous, moderate, and walking activity (minutes/day)
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T1+2 weeks, T1+4 weeks, T1+12 weeks, follow ups: T1+ 6 months, T1+12 months; before & after sports and physical activity module; at baseline: before COVID-19 pandemic
Title
Home-schooling
Description
Questions related to home-schooling related stress & learning
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T1+2 weeks, T1+4 weeks, T1+12 weeks, follow ups: T1+ 6 months, T1+12 months; before & after sports and physical activity module; at baseline: before COVID-19 pandemic
Title
Information related to COVID-19 and SARS-CoV-2
Description
Questions related to COVID-19 and SARS-CoV-2 symptoms, disease, and testing, anxiety, stressors
Time Frame
baseline before waiting (T0, arm 2 only); baseline before online support (day 1, T1), T1+2 weeks, T1+4 weeks, T1+12 weeks, follow ups: T1+ 6 months, T1+12 months; before & after the sports and physical activity module of the online intervention
Title
Unintended effects
Description
Unintended effects of online support program
Time Frame
only after undergoing online support program: T1+2 weeks, T1+4 weeks, T1+12 weeks, follow ups: T1+ 6 months, T1+12 months

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion criteria, general: Sufficient German language skills to participate in the assessments. Providing informed consent for participation. Inclusion criteria for the arms "Online support program" and "Waiting condition...": - Having signed up for the online support program provided by selfapy GmbH, Berlin, Germany (www.selfapy.de/corona) aiming at reducing burden in the context of the COVID-19 pandemic. Inclusion criteria for the arm "No intervention...": - Not having signed up for the online support program provided by selfapy GmbH, Berlin, Germany (www.selfapy.de/corona) aiming at reducing burden in the context of the COVID-19 pandemic.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Gunther Meinlschmidt, Prof. Dr.
Phone
+49 30 300117
Ext
710
Email
gunther.meinlschmidt@ipu-berlin.de
Facility Information:
Facility Name
Selfapy GmbH
City
Berlin
ZIP/Postal Code
10435
Country
Germany
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Kati Bermbach
Phone
+49 (0) 30 - 3982031
Ext
20
Email
contact@selfapy.com

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

DIgital Online SuPport for COVID-19 StrEss

We'll reach out to this number within 24 hrs